Acute effects of delta-9-tetrahydrocannabinol on performance monitoring in healthy volunteers

Frontiers in Behavioral Neuroscience

Volumn , Issue SEPTEMBER, 2011, Pages

  Spronk, Desirée ^a,b   Dumont, Glenn J H ^a,c   Verkes, Robbert J ^a,b   de Bruijn, Ellen R A ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY   (Netherlands)

^c Moleman Psychopharmacology   (Netherlands)

Author keywords

Cannabinoids; Cannabis; ERN; Error related negativity; Human; Performance monitoring; THC

Indexed keywords

CANNABIS; DRONABINOL; PLACEBO;

ACTION POTENTIAL; ADULT; ARTICLE; ARTIFACT; BEHAVIOR; BLOOD SAMPLING; CIGARETTE SMOKING; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ELECTROENCEPHALOGRAM; ERROR RELATED NEGATIVITY; EVENT RELATED POTENTIAL; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; REACTION TIME; RESPONSE TIME; TASK PERFORMANCE; VAPOR; VISUAL FEEDBACK;

EID: 84855497630     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2011.00059     Document Type: Article

References (81)

1. Abrams, D. I., Vizoso, H. P., Shade, S. B., Jay, C., Kelly, M. E., and Benowitz, N. L. (2007). Vaporization as a smokeless cannabis delivery system: a pilot study. Clin. Pharmacol. Ther. 82, 572-578.
2. Ashton, C. H. (1999). Adverse effects of cannabis and cannabinoids. Br. J. Anaesth. 83, 637-649.
3. Bartholow, B. D., Henry, E. A., Lust, S. A., Saults, J. S., and Wood, P. K. (in press). Alcohol effects on performance monitoring and adjustment: affect modulation and impairment of evaluative cognitive control. J. Abnorm. Psychol. doi: 10.1037/a0023664. [Epub ahead of print].
4. Bernstein, P. S., Scheffers, M. K., and Coles, M. G. H. (1995). "Where did I go wrong?" A psychophysiological analysis of error detection. J. Exp. Psychol. Hum. Percept. Perform. 21, 1312-1322.
5. Böcker, K. B., Gerritsen, J., Hunault, C. C., Kruidenier, M., Mensinga, T. T., and Kenemans, J. L. (2010). Cannabis with high δ9-THC contents affects perception and visual selective attention acutely: an event-related potential study. Pharmacol. Biochem. Behav. 96, 67-74.
6. Boileau, I., Assaad, J. M., Pihl, R. O., Benkelfat, C., Leyton, M., Diksic, M., Tremblay, R. E., and Dagher, A. (2003). Alcohol promotes dopamine release in the human nucleus accumbens. Synapse 49, 226-231.
7. Boksem, M. A., Meijman, T. F., and Lorist, M. M. (2006). Mental fatigue, motivation and action monitoring. Biol. Psychol. 72, 123-132.
8. Borgwardt, S. J., Allen, P., Bhattacharyya, S., Fusar-Poli, P., Crippa, J. A., Seal, M. L., Fraccaro, V., Atakan, Z., Martin-Santos, R., O'Carroll, C., Rubia, K., and McGuire, PK. (2008). Neural basis of delta-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition. Biol. Psychiatry 64, 966-973.
9. Bossong, M. G., van Berckel, B. N., Boellaard, R., Zuurman, L., Schuit, R. C., Windhorst, A. D., van Gerven, J. M., Ramsey, N. F., Lammertsma, A. A., and Kahn, R. S. (2009). Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum. Neuropsychopharmacology 34, 759-766.
10. Bush, G., Luu, P., and Posner, M. I. (2000). Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn. Sci. (Regul. Ed.) 4, 215-222.
11. Calabria, B., Degenhardt, L., Hall, W., and Lynskey, M. (2010). Does cannabis use increase the risk of death? Systematic review of epidemiological evidence on adverse effects of cannabis use. Drug Alcohol Rev. 29, 318-330.
12. Choi, Y. H., Hazekamp, A., PeltenburgLooman, A. M., Frédérich, M., Erkelens, C., Lefeber, A. W., and Verpoorte, R. (2004). NMR assignments of the major cannabinoids and cannabiflavonoids isolated from flowers of Cannabis sativa. Phytochem. Anal. 15, 345-354.
13. Coull, J. T. (1998). Neural correlates of attention and arousal: insights from electrophysiology, functional neuroimaging and psychopharmacology. Prog. Neurobiol. 55, 343-361.
14. Crean, R. D., Crane, N. A., and Mason, B. J. (2011). An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions. J. Addict. Med. 5, 1-8.
15. Curran, H. V., Brignell, C., Fletcher, S., Middleton, P., and Henry, J. (2002). Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users. Psychopharmacology (Berl.) 164, 61-70.
16. de Bruijn, E. R. A., Hulstijn, W., Verkes, R. J., Ruigt, G. S. F., and Sabbe, B. G. C. (2004). Drug-induced stimulation and suppression of action monitoring in healthy volunteers. Psychopharmacology (Berl.) 177, 151-160.
17. de Bruijn, E. R. A., Sabbe, B. G., Hulstijn, W., Ruigt, G. S. F., and Verkes, R. J. (2006). Effects of antipsychotic and antidepressant drugs on action monitoring in healthy volunteers. Brain Res. 1105, 122-129.
18. Debener, S., Ullsperger, M., Siegel, M., Fiehler, K., von Cramon, D. Y., and Engel, A. K. (2005). Trial-bytrial coupling of concurrent electroencephalogram and functional magnetic resonance imaging identifies the dynamics of performance monitoring. J. Neurosci. 25, 11730-11737.
19. Dumont, G. J. H., Kramers, C., Sweep, F. C., Touw, D. J., van Hasselt, J. G., de Kam, M., van Gerven, J. M., Buitelaar, J. K., and Verkes, R. J. (2009). Cannabis coadministration potentiates the effects of "ecstasy" on heart rate and temperature in humans. Clin. Pharmacol. Ther. 86, 160-166.
20. Dumont, G. J. H., van Hasselt, J. G., de Kam, M., van Gerven, J. M., Touw, D. J., Buitelaar, J. K., and Verkes, R. J. (2011). Acute psychomotor, memory and subjective effects of MDMA and THC co-administration over time in healthy volunteers. J. Psychopharmacol. (Oxford) 25, 478-489.
21. Elikkottil, J., Elikottil, J., Gupta, P., and Gupta, K. (2009). The analgesic potential of cannabinoids. J. Opioid Manag. 5, 341-357.
22. Eriksen, B. A., and Eriksen, C. W. (1974). Effects of noise letters upon the identification of a target letter in a nonsearch task. Percept. Psychophys. 16, 143-149.
23. Falkenstein, M., Hohnsbein, J., Hoormann, J., and Blanke, L. (1990). "Effects of errors in choice reaction tasks on the ERP under focused and divided attention," in Psychophysiological Brain Research, eds C. H. M. Brunia, A. W. K. Gaillard, and A. Kok (Tilburg: Tilburg University Press), 192-195).
24. Falkenstein, M., Hohnsbein, J., Hoormann, J., and Blanke, L. (1991). Effects of crossmodal divided attention on late ERP components. II. Error processing in choice reaction tasks. Electroencephalogr. Clin. Neurophysiol. 78, 447-455.
25. First, M. B., Frances, A. J., Pincus, H., Vettorello, N., and Davis, W. W. (1994). DSM-IV in progress. Changes in substance-related, schizophrenic, and other primarily adult disorders. Hosp. Community Psychiatry 45, 18-20.
26. Fusar-Poli, P., Crippa, J. A., Bhattacharyya, S., Borgwardt, S. J., Allen, P., Martin-Santos, R., Seal, M., Surguladze, S. A., O'Carrol, C., Atakan, Z., Zuardi, A. W., and McGuire, P. K. (2009). Distinct effects of δ9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Arch. Gen. Psychiatry 66, 95-105.
27. Ganushchak, L. Y., and Schiller, N. O. (2008). Motivation and semantic context affect brain error-monitoring activity: an event-related brain potentials study. Neuroimage 39, 395-405.
28. Gehring, W. J., Goss, W., Coles, M. G. H., Meyer, D. E., and Donchin, E. (1993). A neural system for error detection and compensation. Psychol. Sci. 4, 385-390.
29. Glass, M., Dragunow, M., and Faull, R. L. (1997). Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 77, 299-318.
30. Gonzalez, R. (2007). Acute and nonacute effects of cannabis on brain functioning and neuropsychological performance. Neuropsychol. Rev. 17, 347-361.
31. Gratton, G., Coles, M. G., and Donchin, E. (1983). A new method for offline removal of ocular artifact. Electroencephalogr. Clin. Neurophysiol. 55, 468-484.
32. Green, B., Kavanagh, D., and Young, R. (2003). Being stoned: a review of self-reported cannabis effects. Drug Alcohol Rev. 22, 453-460.
33. Hazekamp, A., Choi, Y. H., and Verpoorte, R. (2004). Quantitative analysis of cannabinoids from Cannabis sativa using 1H-NMR. Chem. Pharm. Bull. 52, 718-721.
34. Hazekamp, A., Ruhaak, R., Zuurman, L., van Gerven, J., and Verpoorte, R. (2006). Evaluation of a vaporizing device (Volcano) for the pulmonary administration of tetrahydrocannabinol. J. Pharm. Sci. 95, 1308-1317.
35. Herrmann, M. J., Römmler, J., Ehlis, A. C., Heidrich, A., and Fallgatter, A. J. (2004). Source localization (LORETA) of the error-relatednegativity (ERN/Ne) and positivity (Pe). Brain Res. Cogn. Brain Res. 20, 294-299.
36. Hester, R., Nestor, L., and Garavan, H. (2009). Impaired error awareness and anterior cingulate cortex hypoactivity in chronic cannabis users. Neuropsychopharmacology 34, 2450-2458.
37. Holroyd, C. B., and Coles, M. G. (2002). The neural basis of human error processing: reinforcement learning, dopamine, and the errorrelated negativity. Psychol. Rev. 109, 679-709.
38. Holroyd, C. B., Nieuwenhuis, S., Yeung, N., and Cohen, J. D. (2003). Errors in reward prediction are reflected in the event-related brain potential. Neuroreport 14, 2481-2484.
39. Holroyd, C. B., and Yeung, N. (2003). Alcohol and error processing. Trends Neurosci. 26, 402-404.
40. Horowitz-Kraus, T., and Breznitz, Z. (2009). Can the error detectionmechanism benefit from training the working memory? A comparison between dyslexics and controls-an ERP study. PLoS ONE 4, e7141. doi: 10.1371/journal.pone.0007141
41. Hunault, C. C., Mensinga, T. T., Böcker, K. B., Schipper, C. M., Kruidenier, M., Leenders, M. E., de Vries, I., and Meulenbelt, J. (2009). Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC). Psychopharmacology (Berl.) 204, 85-94.
42. Jentsch, J. D., Verrico, C. D., Le, D., and Roth, R. H. (1998). Repeated exposure to delta 9tetrahydrocannabinol reduces prefrontal cortical dopamine metabolism in the rat. Neurosci. Lett. 246, 169-172.
43. Jocham, G., and Ullsperger, M. (2009). Neuropharmacology of performance monitoring. Neurosci. Biobehav. Rev. 33, 48-60.
44. Johannes, S., Wieringa, B. M., Nager, W., Dengler, R., and Münte, T. F. (2001). Oxazepam alters action monitoring. Psychopharmacology (Berl.) 155, 100-106.
45. Kenemans, J. L., and Kähkönen, S. (2011). How human electrophysiology informs psychopharmacology: from bottom-up driven processing to top-down control. Neuropsychopharmacology 36, 26-51.
46. Lane, S. D., Cherek, D. R., Tcheremissine, O. V., Lieving, L. M., and Pietras, C. J. (2005). Acute marijuana effects on human risk taking. Neuropsychopharmacology 30, 800-809.
47. Lansbergen, M. M., Dumont, G. J. H., van Gerven, J. M., Buitelaar, J. K., and Verkes, R. J. (2011). Acute effects of MDMA (3,4-methylenedioxymethamphetamine) on EEG oscillations: alone and in combination with ethanol or THC (delta9-tetrahydrocannabinol). Psychopharmacology (Berl.) 213, 745-756.
48. Larson, M. J., and Clayson, P. E. (2011). The relationship between cognitive performance and electrophysiological indices of performance monitoring. Cogn. Affect. Behav. Neurosci. 11, 159-171.
49. Lorist, M. M., Boksem, M. A., and Ridderinkhof, K. R. (2005). Impaired cognitive control and reduced cingulate activity during mental fatigue. Brain Res. Cogn. Brain Res. 24, 199-205.
50. Lupica, C. R., Riegel, A. C., and Hoffman, A. F. (2004). Marijuana and cannabinoid regulation of brain reward circuits. Br. J. Pharmacol. 143, 227-234.
51. Luu, P., Flaisch, T., and Tucker, D. M. (2000). Medial frontal cortex in action monitoring. J. Neurosci. 20, 464-469.
52. Machado Rocha, F. C., Stéfano, S. C., De Cássia Haiek, R., Rosa Oliveira, L. M., and Da Silveira, D. X. (2008). Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis. Eur. J. Cancer Care (Engl.) 170.17, 431-443.
53. Martín-Santos, R., Fagundo, A. B., Crippa, J. A., Atakan, Z., Bhattacharyya, S., Allen, P., Fusar-Poli, P., Borgwardt, S., Seal, M., Busatto, G. F., and McGuire, P. (2010). Neuroimaging in cannabis use: a systematic review of the literature. Psychol. Med. 40, 383-398.
54. McDonald, J., Schleifer, L., Richards, J. B., and de Wit, H. (2003). Effects of THC on behavioral measures of impulsivity in humans. Neuropsychopharmacology 28, 1356-1365.
55. Muntoni, A. L., Pillolla, G., Melis, M., Perra, S., Gessa, G. L., and Pistis, M. (2006). Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons. Eur. J. Neurosci. 23, 2385-2394.
56. Nijboer, F., Birbaumer, N., and Kübler, A. (2010). The influence of psychological state and motivation on brain-computer interface performance in patients with amyotrophic lateral sclerosis a longitudinal study. Front. Neurosci. 4:5 doi: 10.3389/fnins.2010.00055
57. Pailing, P. E., and Segalowitz, S. J. (2004). The effects of uncertainty in error monitoring on associated ERPs. Brain Cogn. 56, 215-233.
58. Pattij, T., Wiskerke, J., and Schoffelmeer, A. N. (2008). Cannabinoid modulation of executive functions. Eur. J. Pharmacol. 585, 458-463.
59. Penning, R., Veldstra, J. L., Daamen, A. P., Olivier, B., and Verster, J. C. (2010). Drugs of abuse, driving and traffic safety. Curr. Drug Abuse Rev. 3, 23-32.
60. Pistis, M., Ferraro, L., Pira, L., Flore, G., Tanganelli, S., Gessa, G. L., and Devoto, P. (2002). Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study. Brain Res. 948, 155-158.
61. Rabbitt, P. M. A. (1966). Errors and error correction in choice-response tasks. J. Exp. Psychol. 71, 264-272.
62. Ramaekers, J. G.,Kauert, G., vanRuitenbeek, P., Theunissen, E. L., Schneider, E., and Moeller, M. R. (2006). Highpotency marijuana impairs executive function and inhibitory motor control. Neuropsychopharmacology 31, 2296-2303.
63. Ramaekers, J. G., Kauert, G., Theunissen, E. L., Toennes, S. W., and Moeller, M. R. (2009). Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users. J Psychopharmacol. 23, 266-277.
64. Ranganathan, M., and D'Souza, D. C. (2006). The acute effects of cannabinoids on memory in humans: a review. Psychopharmacology (Berl.) 188, 425-444.
65. Riba, J., Rodríguez-Fornells, A., Münte, T. F., and Barbanoj, M. J. (2005). A neurophysiological study of the detrimental effects of alprazolam on human action monitoring. Brain Res. Cogn. Brain Res. 25, 554-565.
66. Ridderinkhof, K. R., de Vlugt, Y., Bramlage, A., Spaan, M., Elton, M., Snel, J., and Band, G. P. (2002). Alcohol consumption impairs detection of performance errors in mediofrontal cortex. Science 298, 2209-2211.
67. Russo, E., and Guy, G. W. (2005). A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. Med. Hypotheses 66, 234-246.
68. Scheffers, M. K., Humphrey, D. G., Stanny, R. R, Kramer, A. F., and Coles, M. G. H. (1999). Errorrelated processing during a period of extended wakefulness. Psychophysiology 36, 149-157.
69. Schellekens, A. F., De Bruijn, E. R. A., van Lankveld, C. A., Hulstijn, W., Buitelaar, J. K., de Jong, C. A., and Verkes, R. J. (2010). Alcohol dependence and anxiety increase error-related brain activity. Addiction 105, 1928-1934.
70. Schrijvers, D., De Bruijn, E. R. A., Maas, Y. J., Vancoillie, P., Hulstijn, W., and Sabbe, B. G. (2009). Action monitoring and depressive symptom reduction in major depressive disorder. Int. J. Psychophysiol. 71, 218-224.
71. Segalowitz, S. J., Santesso, D. L., Murphy, T. I., Homan, D., Chantziantoniou, D. K., and Khan, S. (2010). Retest reliability of medial frontal negativities during performance monitoring. Psychophysiology 47, 260-270.
72. Solowij, N., and Battisti, R. (2008). The chronic effects of cannabis on memory in humans: a review. Curr. Drug Abuse Rev. 1, 81-98.
73. Stemmer, B., Segalowitz, S. J., Witzke, W., and Schönle, P. W. (2004). Error detection in patients with lesions to the medial prefrontal cortex: an ERP study. Neuropsychologia 42, 118-130.
74. Sulzer, D., Sonders, M. S., Poulsen, N. W., and Galli, A. (2005). Mechanisms of neurotransmitter release by amphetamines: a review. Prog. Neurobiol. 75, 406-433.
75. Svrakic, D. M., Whitehead, C., Przybeck, T. R., and Cloninger, C. R. (1993). Differential diagnosis of personality disorders by the sevenfactor model of temperament and character. Arch. Gen. Psychiatry 50, 991-999.
76. Ullsperger, M., and von Cramon, D. Y. (2006). The role of intact frontostriatal circuits in error processing. J. Cogn. Neurosci. 18, 651-664.
77. Ullsperger, M., von Cramon, D. Y., and Müller, N. G. (2002). Interactions of focal cortical lesions with error processing: evidence from eventrelated brain potentials. Neuropsychology 16, 548-561.
78. Verrico, C. D., Jentsch, J. D., Roth, R. H., and Taylor, J. R. (2004). Repeated, intermittent delta(9)-tetrahydrocannabinol administration to rats impairs acquisition and performance of a test of visuospatial divided attention. Neuropsychopharmacology 29, 522-529.
79. Vicente, J., Olszewski, D., and Matias, J. (2008). "Prevalence, patterns and trends of cannabis use among adults in Europe," in A Cannabis Reader: Global Issues and Local Experiences. eds S. Rödner Sznitman, B. Olsson, and R. Room (Lisbon: European Monitoring Center on Drug and Drug Addiction), 1-26.
80. Yeung, N., Botvinick, M. M., and Cohen, J. D. (2004). The neural basis of error detection: conflict monitoring and the error-related negativity. Psychol. Rev. 111, 931-959.
81. Zirnheld, P. J., Carroll, C. A., Kieffaber, P. D., O'Donnell, B. F., Shekhar, A., and Hetrick, W. P. (2004). Haloperidol impairs learning and error-related negativity in humans. J. Cogn. Neurosci. 16, 1098-1112.